These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 382866)

  • 1. The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells.
    Poste G
    Am J Pathol; 1979 Aug; 96(2):595-610. PubMed ID: 382866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G; Kirsh R; Fogler WE; Fidler IJ
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective tumoricidal capacity of macrophages from C3H/HeJ mice.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Jan; 120(1):329-34. PubMed ID: 627723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel rat monoclonal antibody reactive with murine tumoricidal Kupffer cells and activated peritoneal macrophages from BCG-infected mice.
    Someya A
    Immunology; 1986 Apr; 57(4):605-10. PubMed ID: 2420709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of multinucleated giant cells formed by fusing rat alveolar macrophages with lymphokines containing macrophage fusion factor.
    Sone S
    Lymphokine Res; 1984; 3(4):163-73. PubMed ID: 6333567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
    Paulnock DM; Lambert LE
    J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokines and bacteria, that induce tumoricidal activity, trigger a different secretory response in macrophages.
    Keller R; Keist R; Frei K
    Eur J Immunol; 1990 Mar; 20(3):695-8. PubMed ID: 2108046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
    Stuehr DJ; Marletta MA
    J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.